69
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Unveiling therapeutic prospects: targeting MDM-2 in non-muscle invasive bladder cancer

, &
Received 20 Dec 2023, Accepted 06 Mar 2024, Published online: 18 Mar 2024

References

  • Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). Gromacs: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1-2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
  • Bell, J. A., Cao, Y., Gunn, J. R., Day, T., Gallicchio, E., Zhou, Z., et al. (2012). PrimeX and the Schrödinger computational chemistry suite of programs(pp. 534–538).
  • Cai, Z., Zhang, F., Chen, W., Zhang, J., & Li, H. (2019). Mirnas: A promising target in the chemoresistance of bladder cancer. OncoTargets and Therapy, 12, 11805–11816. https://doi.org/10.2147/OTT.S231489
  • Cancer Index. (1996). National and international cancer organisations. CancerIndex. Available from: http://www.cancerindex.org/clinks7.htm
  • Dallakyan, S., & Olson, A. J. (2015). Small-molecule library screening by docking with PyRx. Methods in Molecular Biology (Clifton, N.J.), 1263, 243–250. https://doi.org/10.1007/978-1-4939-2269-7_19
  • Eberhardt, J., Santos-Martins, D., Tillack, A. F., & Forli, S. (2021). AutoDock Vina 1.2.0: New docking methods, expanded force field, and python bindings. Journal of Chemical Information and Modeling, 61(8), 3891–3898. https://doi.org/10.1021/acs.jcim.1c00203
  • Gómez-Rubio, V. (2017). ggplot2 - Elegant graphics for data analysis (2nd Edition). Journal of Statistical Software, 77(2), 1-3. https://doi.org/10.18637/jss.v077.b02
  • Huang, J., & Mackerell, A. D. (2013). CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR data. Journal of Computational Chemistry, 34(25), 2135–2145. https://doi.org/10.1002/jcc.23354
  • Khoutoul, M., Djedouani, A., Lamsayah, M., Abrigach, F., & Touzani, R. (2016). Liquid-liquid extraction of metal ions, DFT and TD-DFT analysis for some pyrane derivatives with high selectivity for Fe(II) and Pb(II). Separation Science and Technology. 51(7), 1112–1123. https://doi.org/10.1080/01496395.2015.1107583
  • Kim, D., Paggi, J. M., Park, C., Bennett, C., & Salzberg, S. L. (2019). Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nature Biotechnology, 37(8), 907–915. https://doi.org/10.1038/s41587-019-0201-4
  • Li, H.-J., Gong, X., Li, Z.-K., Qin, W., He, C.-X., Xing, L., Zhou, X., Zhao, D., & Cao, H.-L. (2021). Role of long non-coding RNAs on bladder cancer. Frontiers in Cell and Developmental Biology, 9, 672679. https://doi.org/10.3389/fcell.2021.672679
  • Li, Y., Sun, L., Guo, X., Mo, N., Zhang, J., & Li, C. (2021). Frontiers in Bladder cancer genomic research. Frontiers in Oncology, 11, 670729. https://doi.org/10.3389/fonc.2021.670729
  • Mark, P., & Nilsson, L. (2001). Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. The Journal of Physical Chemistry A, 105(43), 9954–9960. https://doi.org/10.1021/jp003020w
  • Martin-Doyle, W., & Kwiatkowski, D. J. (2015). Molecular biology of bladder cancer. Hematology/Oncology Clinics of North America, 29(2), 191–203, vii. https://doi.org/10.1016/j.hoc.2014.10.002
  • Mendoza, M., Mandani, G., & Momand, J. (2014). The MDM2 gene family. Biomolecular Concepts, 5(1), 9–19. https://doi.org/10.1515/bmc-2013-0027
  • Mokou, M., Lygirou, V., Angelioudaki, I., Paschalidis, N., Stroggilos, R., Frantzi, M., Latosinska, A., Bamias, A., Hoffmann, M. J., Mischak, H., & Vlahou, A. (2020). A novel pipeline for drug repurposing for bladder cancer based on patients’ omics signatures. Cancers, 12(12), 3519. https://doi.org/10.3390/cancers12123519
  • Munisamy, M., Mukherjee, N., Thomas, L., Pham, A. T., Shakeri, A., & Zhao, Y. (2021). Therapeutic opportunities in cancer therapy: Targeting the p53-MDM2/MDMX interactions. American Journal of Cancer Research, 11(12), 5762–5781.
  • Oyedele, A.-Q K., Adelusi, T. I., Ogunlana, A. T., Adeyemi, R. O., Atanda, O. E., Babalola, M. O., Ashiru, M. A., Ayoola, I. J., & Boyenle, I. D. (2022). Integrated virtual screening and molecular dynamics simulation revealed promising drug candidates of p53-MDM2 interaction. Journal of Molecular Modeling, 28(6), 142. https://doi.org/10.1007/s00894-022-05131-w
  • Pertea, M., Kim, D., Pertea, G. M., Leek, J. T., & Salzberg, S. L. (2016). Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown. Nature Protocols, 11(9), 1650–1667. https://doi.org/10.1038/nprot.2016-095
  • Pertea, M., Pertea, G. M., Antonescu, C. M., Chang, T. C., Mendell, J. T., & Salzberg, S. L. (2015). StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nature Biotechnology, 33(3), 290–295. https://doi.org/10.1038/nbt.3122
  • Shaheen, M. F., Segar, J. M., Chmielowski, B., Drabick, J. J., McKean, M., Reeves, J. A., Karapetis, C. S., Orloff, M. M., Tolcher, A. W., Beck, J. T. T., Gastman, B., De, A., Paudyal, B., Winkler, R. E., Li, M., Ahmad, M., Yang, D., & Zhai, Y. (2023). A phase 2 study of alrizomadlin (APG-115) in combination with pembrolizumab in patients with unresectable or metastatic cutaneous melanoma that has failed immuno-oncologic (IO) drugs. Journal of Clinical Oncology, 41(16_suppl), 9559–9559. https://doi.org/10.1200/JCO.2023.41.16_suppl.9559
  • Shaweta, S., Akhil, S., & Utsav, G. (2021). Molecular docking studies on the anti-fungal activity of Allium sativum (Garlic) against Mucormycosis (black fungus) by BIOVIA discovery studio visualizer 21.1.0.0. Annals of Antivirals and Antiretrovirals, 5(1), 28–32. https://doi.org/10.17352/aaa.000013
  • Somaiah, N., Van Tine, B. A., Chmielowski, B., Drabick, J. J., Chawla, S. P., McKean, M., Spira, A. I., O'Byrne, K. J., Foresto, S. A., Movva, S., Kim, A., Gastman, B., Pressey, J. G., Paudyal, B., De, A., Winkler, R. E., Li, M., Ahmad, M., Yang, D., & Zhai, Y. (2023). A phase 2 study of alrizomadlin, a novel MDM2/p53 inhibitor, in combination with pembrolizumab for treatment of patients with malignant peripheral nerve sheath tumor (MPNST). Journal of Clinical Oncology, 41(16_suppl), e14627–e14627. https://doi.org/10.1200/JCO.2023.41.16_suppl.e14627
  • Steinberg, R. L., Thomas, L. J., & O'Donnell, M. A. (2018). Combination intravesical chemotherapy for non–muscle-invasive bladder cancer. European Urology Focus, 4(4), 503–505. https://doi.org/10.1016/j.euf.2018.07.005
  • Tran, L., Xiao, J. F., Agarwal, N., Duex, J. E., & Theodorescu, D. (2021). Advances in bladder cancer biology and therapy. Nature Reviews. Cancer, 21(2), 104–121. https://doi.org/10.1038/s41568-020-00313-1
  • Vanommeslaeghe, K., Hatcher, E., Acharya, C., Kundu, S., Zhong, S., Shim, J., Darian, E., Guvench, O., Lopes, P., Vorobyov, I., & Mackerell, A. D. (2010). CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. Journal of Computational Chemistry, 31(4), 671–690. https://doi.org/10.1002/jcc.21367
  • Wickham, H., Averick, M., Bryan, J., Chang, W., McGowan, L., François, R., Grolemund, G., Hayes, A., Henry, L., Hester, J., Kuhn, M., Pedersen, T., Miller, E., Bache, S., Müller, K., Ooms, J., Robinson, D., Seidel, D., Spinu, V., … Yutani, H. (2019). Welcome to the tidyverse. Journal of Open Source Software, 4(43), 1686. https://doi.org/10.21105/joss.01686
  • Zhao, Y., Yu, H., & Hu, W. (2014). The regulation of MDM2 oncogene and its impact on human cancers. Acta Biochimica et Biophysica Sinica, 46(3), 180–189. https://doi.org/10.1093/abbs/gmt147

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.